| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| LINDAHL RICHARD S | EVP, Chief Financial Officer | 300 PROFESSIONAL DRIVE, GAITHERSBURG | /s/ Richard S. Lindahl | 10 Feb 2026 | 0001196632 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EBS | Common Stock | Disposed to Issuer | $504,013 | -46,155 | -16% | $10.92 | 245,342 | 06 Feb 2026 | Direct | F1 |
| transaction | EBS | Common Stock | Tax liability | $61,611 | -5,642 | -2.3% | $10.92 | 239,700 | 06 Feb 2026 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to both cumulative revenues and adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2023 and ending December 31, 2025. On February 06, 2026, the final certification date, the Compensation Committee certified the achievement of the 2023-2025 PSUs at a payout factor of 25% of target resulting in the actual award of 15,384 shares of common stock, which is less than the 61,539 shares previously reported on March 02, 2023 and June 09, 2023. |
| F2 | Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units |